12 In-Stock, Recyclable, Lightweight Tissue Paper Designs for Your Christmas 2022 Packaging

Halloween is just around the corner, marking for many in the United States the start of a busy holiday season. And the one holiday on every retailer’s mind is, of course, Christmas. Christmas spending is an annual opportunity to increase sales and create new customers for your business. As we know, custom packaging is an effective way to achieve brand-loyal customers during this key time period.

Who doesn’t get a thrill out of receiving a package that’s been carefully branded and designed? Premium packaging is a proven tool to build a connection with your customer and imparts a sense of quality about the brand. With consumers ordering more online and in-store than any other time of the year, custom, holiday-themed packaging is an easy and cost-effective way to stand out from your competition.

Custom holiday packaging require businesses to plan ahead during the first half of the year. It’s been a busy year for everyone in retail and, now that fall is already here, ordering custom packaging for the upcoming season might not be possible due to the reality of lead times. Think that means it’s too late to incorporate special holiday packaging for the 2022 season? Think again. Seaman Paper has your business covered with 12 in-stock and ready-to-ship holiday tissue paper designs.
more at: https://www.seamanpaper.com/blog/12-days-of-satinwrap-christmas

Related Posts

Berry Global Group, Inc. Reports Strong First Quarter 2021 Results

First Quarter Highlights (all comparisons made to the December 2019 quarter) *Net sales of $3.1 billion; 7 percent organic volume growth *Operating income up 53 percent to $304 million *Operating EBITDA up 20 percent to $539 million *Increased fiscal 2021 organic volume growth assumption by 2 percent, now targeting 4 percent. Berry’s Chairman and CEO Tom Salmon said, “Berry’s fiscal 2021 is off to an exceptional start with record first quarter financial results exceeding our expectations. Consumer demand for our products remains consistent and certain markets which previously experienced COVID-19 headwinds are rebounding quicker than we expected.

Mondi acquires two paper bag lines and signs exclusive supplier agreements with leading cement producers in Egypt

Mondi Paper Bags has acquired two paper bag lines from Helwan Cement Company and InterCement Sacs, two major cement producers in Egypt. The acquired production lines will increase Mondi’s capacity by approximately 60-80 million bags annually and strengthen Mondi's position in the Middle Eastern bag market, particularly in supporting suppliers to the construction industry. Mondi Paper Bags, a global producer that operates two plants in Egypt, will also become the exclusive supplier of paper bags to Helwan Cement Company and InterCement Sacs. "We are excited to have signed long-term supply agreements with two of our biggest customers in Egypt further securing our position in the Middle Eastern market.

Metsä Board’s simulation and testing services help develop secure pharma packaging

Ensuring that vaccine vials and their potentially life-changing contents remain safe, sterile and identifiable throughout their tightly controlled supply chain is no easy task, and taking risks is not an option. With the new extended 360 Service offering, Metsä Board, part of Metsä Group, is testing the paperboards and simulating packaging designs used by pharma manufacturers to package and protect vaccine doses, providing absolute confidence that the materials are up to the task. COVID-19 and other vaccines are typically stored and transported in extremely cold conditions, which can be as low as -70 degrees Celsius, before being thawed out ready for administration. The secondary paperboard packaging must be able to withstand these temperature extremes and protect the vials throughout the entire process. When a converter is producing packages for cold-chain transportation they have to be 100% certain that the materials they are using are appropriate. This is where Metsä Board’s in-depth testing and simulation capabilities are extremely valuable for the pharma industry.
Back To Top
×Close search
Search